A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients

The soy compound genistein has been observed preclinically to inhibit bladder cancer growth with one potential mechanism being inhibition of epidermal growth factor receptor phosphorylation (p-EGFR). A phase 2 randomized, placebo-controlled trial investigated whether daily, oral genistein (300 or 60...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Messing, Edward, Gee, Jason R., Saltzstein, Daniel R., Kim, KyungMann, diSant’Agnese, Anthony, Kolesar, Jill, Harris, Linda, Faerber, Adrienne, Havighurst, Thomas, Young, Jay M., Efros, Mitchell, Getzenberg, Robert H., Wheeler, Marcia A., Tangrea, Joseph, Parnes, Howard, House, Margaret, Busby, J. Erik, Hohl, Raymond, Bailey, Howard
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3324663/
https://ncbi.nlm.nih.gov/pubmed/22293631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-11-0455
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg